{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:05:45Z","timestamp":1794585945709,"version":"4.9.1"},"publisher-location":"Cham","reference-count":139,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319997155","type":"print"},{"value":"9783319997162","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-319-99716-2_1","type":"book-chapter","created":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T11:33:57Z","timestamp":1546169637000},"page":"1-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epidemiology and Pathology of T- and NK-Cell Lymphomas"],"prefix":"10.1007","author":[{"given":"Parwiz J.","family":"Siaghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Y.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"key":"1_CR1","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues (ed revised 4th), International agency for research on cancer lyon"},{"issue":"6","key":"1_CR2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/PAS.0000000000000188","volume":"38","author":"ED Hsi","year":"2014","unstructured":"Hsi ED, Said J, Macon WR et al (2014) Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T\/NK-cell lymphomas. A North American PTCL study group project. Am J Surg Pathol 38(6):768\u2013775","journal-title":"Am J Surg Pathol"},{"issue":"19","key":"1_CR3","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C et al (2014) Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123(19):2915\u20132923","journal-title":"Blood"},{"issue":"20","key":"1_CR4","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"issue":"25","key":"1_CR5","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124\u20134130","journal-title":"J Clin Oncol"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-62703-170-7_2","volume-title":"T-cell lymphomas","author":"SS Wang","year":"2013","unstructured":"Wang SS, Vose JM (2013) Epidemiology and prognosis of T-cell lymphoma. In: Foss F (ed) T-cell lymphomas. Humana Press, Totowa, NJ, pp 25\u201339"},{"issue":"2","key":"1_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","volume":"64","author":"AD Attygalle","year":"2014","unstructured":"Attygalle AD, Cabecadas J, Gaulard P et al (2014) Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward\u2014report on the lymphoma workshop of the XVIth meeting of the European association for haematopathology and the society for hematopathology. Histopathology 64(2):171\u2013199","journal-title":"Histopathology"},{"issue":"5","key":"1_CR8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","volume":"33","author":"Y Huang","year":"2009","unstructured":"Huang Y, Moreau A, Dupuis J et al (2009) Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 33(5):682\u2013690","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"1_CR9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","volume":"32","author":"SM Rodriguez-Pinilla","year":"2008","unstructured":"Rodriguez-Pinilla SM, Atienza L, Murillo C et al (2008) Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol 32(12):1787\u20131799","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"1_CR10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.humpath.2012.05.002","volume":"43","author":"S Hu","year":"2012","unstructured":"Hu S, Young KH, Konoplev SN, Medeiros LJ (2012) Follicular T-cell lymphoma: a member of an emerging family of follicular helper T-cell derived T-cell lymphomas. Hum Pathol 43(11):1789\u20131798","journal-title":"Hum Pathol"},{"issue":"9","key":"1_CR11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide O, Weigert O, Lane AA et al (2014) A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 123(9):1293\u20131296","journal-title":"Blood"},{"issue":"7","key":"1_CR12","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","volume":"120","author":"F Lemonnier","year":"2012","unstructured":"Lemonnier F, Couronne L, Parrens M et al (2012) Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 120(7):1466\u20131469","journal-title":"Blood"},{"issue":"3","key":"1_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","volume":"40","author":"SL Ondrejka","year":"2016","unstructured":"Ondrejka SL, Grzywacz B, Bodo J et al (2016) Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val mutation have classic clinical and pathologic features. Am J Surg Pathol 40(3):335\u2013341","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"1_CR14","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.2012.181","volume":"26","author":"ES Jaffe","year":"2013","unstructured":"Jaffe ES, Nicolae A, Pittaluga S (2013) Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls. Mod Pathol 26(Suppl 1):S71\u201387","journal-title":"Mod Pathol"},{"issue":"7","key":"1_CR15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","volume":"31","author":"AD Attygalle","year":"2007","unstructured":"Attygalle AD, Kyriakou C, Dupuis J et al (2007) Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 31(7):1077\u20131088","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1_CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/modpathol.2009.12","volume":"22","author":"M Rodriguez-Justo","year":"2009","unstructured":"Rodriguez-Justo M, Attygalle AD, Munson P, Roncador G, Marafioti T, Piris MA (2009) Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. Mod Pathol 22(6):753\u2013761","journal-title":"Mod Pathol"},{"issue":"6","key":"1_CR17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","volume":"37","author":"A Nicolae","year":"2013","unstructured":"Nicolae A, Pittaluga S, Venkataraman G et al (2013) Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol 37(6):816\u2013826","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1_CR18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","volume":"117","author":"A Zettl","year":"2002","unstructured":"Zettl A, Lee S, Rudiger T et al (2002) Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 117(3):368\u2013379","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"1_CR19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M et al (2013) Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol 31(2):240\u2013246","journal-title":"J Clin Oncol"},{"issue":"4","key":"1_CR20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2559.2011.03981.x","volume":"59","author":"C Agostinelli","year":"2011","unstructured":"Agostinelli C, Hartmann S, Klapper W et al (2011) Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert\u2019s personal archive. Histopathology. 59(4):679\u2013691","journal-title":"Histopathology."},{"issue":"11","key":"1_CR21","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","volume":"36","author":"J Moroch","year":"2012","unstructured":"Moroch J, Copie-Bergman C, de Leval L et al (2012) Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol 36(11):1636\u20131646","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"1_CR22","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L Leval de","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C et al (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109(11):4952\u20134963","journal-title":"Blood"},{"issue":"4","key":"1_CR23","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","volume":"102","author":"MP Dobay","year":"2017","unstructured":"Dobay MP, Lemonnier F, Missiaglia E et al (2017) Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica 102(4):e148\u2013e151","journal-title":"Haematologica"},{"issue":"2","key":"1_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B Streubel","year":"2006","unstructured":"Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A (2006) Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 20(2):313\u2013318","journal-title":"Leukemia"},{"issue":"15","key":"1_CR25","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1158\/0008-5472.CAN-08-3719","volume":"70","author":"C Dierks","year":"2010","unstructured":"Dierks C, Adrian F, Fisch P et al (2010) The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease. Cancer Res 70(15):6193\u20136204","journal-title":"Cancer Res"},{"issue":"9","key":"1_CR26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","volume":"37","author":"AD Attygalle","year":"2013","unstructured":"Attygalle AD, Feldman AL, Dogan A (2013) ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 37(9):1456\u20131457","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1_CR27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","volume":"107","author":"MA Rizvi","year":"2006","unstructured":"Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST (2006) T-cell non-Hodgkin lymphoma. Blood 107(4):1255\u20131264","journal-title":"Blood"},{"issue":"12","key":"1_CR28","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/PAS.0000000000000503","volume":"39","author":"MP Menon","year":"2015","unstructured":"Menon MP, Nicolae A, Meeker H et al (2015) Primary CNS T-cell Lymphomas: a clinical, morphologic, immunophenotypic, and molecular analysis. Am J Surg Pathol 39(12):1719\u20131729","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"1_CR29","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.humpath.2013.03.002","volume":"44","author":"E Hayashi","year":"2013","unstructured":"Hayashi E, Takata K, Sato Y et al (2013) Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphoma. Hum Pathol 44(9):1927\u20131936","journal-title":"Hum Pathol"},{"key":"1_CR30","doi-asserted-by":"crossref","unstructured":"Bellei M, Sabattini E, Pesce EA et al (2016) Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study. Hematol Oncol","DOI":"10.1002\/hon.2316"},{"issue":"10","key":"1_CR31","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/PAS.0000000000000295","volume":"38","author":"SH Swerdlow","year":"2014","unstructured":"Swerdlow SH, Jaffe ES, Brousset P et al (2014) Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies. Am J Surg Pathol 38(10):e60\u201371","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"1_CR32","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A et al (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24(16):2472\u20132479","journal-title":"J Clin Oncol"},{"issue":"8","key":"1_CR33","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3324\/haematol.2013.084913","volume":"98","author":"E Sabattini","year":"2013","unstructured":"Sabattini E, Pizzi M, Tabanelli V et al (2013) CD30 expression in peripheral T-cell lymphomas. Haematologica 98(8):e81\u201382","journal-title":"Haematologica"},{"issue":"12","key":"1_CR34","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","volume":"27","author":"TS Barry","year":"2003","unstructured":"Barry TS, Jaffe ES, Sorbara L, Raffeld M, Pittaluga S (2003) Peripheral T-cell lymphomas expressing CD30 and CD15. Am J Surg Pathol 27(12):1513\u20131522","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1_CR35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00428-004-1077-2","volume":"445","author":"E Geissinger","year":"2004","unstructured":"Geissinger E, Odenwald T, Lee SS et al (2004) Nodal peripheral T-cell lymphomas and in particular, their lymphoepithelioid (Lennert\u2019s) variant are often derived from CD8(+) cytotoxic T-cells. Virchows Arch 445(4):334\u2013343","journal-title":"Virchows Arch"},{"issue":"6","key":"1_CR36","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2559.2011.04069.x","volume":"59","author":"S Hartmann","year":"2011","unstructured":"Hartmann S, Agostinelli C, Klapper W et al (2011) Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node registry: what is Lennert\u2019s lymphoma nowadays? Histopathology 59(6):1173\u20131182","journal-title":"Histopathology"},{"issue":"7","key":"1_CR37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.prp.2013.04.013","volume":"209","author":"SY Ha","year":"2013","unstructured":"Ha SY, Sung J, Ju H et al (2013) Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study. Pathol Res Pract 209(7):448\u2013454","journal-title":"Pathol Res Pract"},{"issue":"6","key":"1_CR38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","volume":"127","author":"SH Swerdlow","year":"2007","unstructured":"Swerdlow SH (2007) T-cell and NK-cell posttransplantation lymphoproliferative disorders. Am J Clin Pathol 127(6):887\u2013895","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"1_CR39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","volume":"46","author":"T Palomero","year":"2014","unstructured":"Palomero T, Couronne L, Khiabanian H et al (2014) Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet 46(2):166\u2013170","journal-title":"Nat Genet"},{"issue":"24","key":"1_CR40","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1200\/JCO.2012.42.5611","volume":"31","author":"PP Piccaluga","year":"2013","unstructured":"Piccaluga PP, Fuligni F, De Leo A et al (2013) Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. J Clin Oncol 31(24):3019\u20133025","journal-title":"J Clin Oncol"},{"key":"1_CR41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/bcj.2014.78","volume":"4","author":"MA Laginestra","year":"2014","unstructured":"Laginestra MA, Piccaluga PP, Fuligni F et al (2014) Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified. Blood Cancer J 4:259","journal-title":"Blood Cancer J"},{"issue":"12","key":"1_CR42","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2012-08-447375","volume":"122","author":"C Liu","year":"2013","unstructured":"Liu C, Iqbal J, Teruya-Feldstein J et al (2013) MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood 122(12):2083\u20132092","journal-title":"Blood"},{"issue":"9","key":"1_CR43","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","volume":"28","author":"R Piva","year":"2010","unstructured":"Piva R, Agnelli L, Pellegrino E et al (2010) Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 28(9):1583\u20131590","journal-title":"J Clin Oncol"},{"issue":"19","key":"1_CR44","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","volume":"123","author":"T Wang","year":"2014","unstructured":"Wang T, Feldman AL, Wada DA et al (2014) GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood 123(19):3007\u20133015","journal-title":"Blood"},{"issue":"9","key":"1_CR45","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar ER, Jaffe ES, Said JW et al (2014) ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124(9):1473\u20131480","journal-title":"Blood"},{"issue":"1","key":"1_CR46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","volume":"126","author":"G Hapgood","year":"2015","unstructured":"Hapgood G, Savage KJ (2015) The biology and management of systemic anaplastic large cell lymphoma. Blood 126(1):17\u201325","journal-title":"Blood"},{"issue":"12","key":"1_CR47","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","volume":"96","author":"H Stein","year":"2000","unstructured":"Stein H, Foss HD, Durkop H et al (2000) CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96(12):3681\u20133695","journal-title":"Blood"},{"issue":"1","key":"1_CR48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","volume":"22","author":"X Xing","year":"2015","unstructured":"Xing X, Feldman AL (2015) Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous. Adv Anat Pathol. 22(1):29\u201349","journal-title":"Adv Anat Pathol."},{"issue":"1","key":"1_CR49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","volume":"40","author":"RL King","year":"2016","unstructured":"King RL, Dao LN, McPhail ED et al (2016) Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements. Am J Surg Pathol 40(1):36\u201343","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1_CR50","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PAS.0b013e3182487158","volume":"36","author":"FC Eberle","year":"2012","unstructured":"Eberle FC, Song JY, Xi L et al (2012) Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol 36(5):716\u2013725","journal-title":"Am J Surg Pathol"},{"key":"1_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.humpath.2017.01.003","volume":"64","author":"X Wang","year":"2017","unstructured":"Wang X, Boddicker RL, Dasari S et al (2017) Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Hum Pathol 64:19\u201327","journal-title":"Hum Pathol"},{"issue":"2","key":"1_CR52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","volume":"32","author":"RN Miranda","year":"2014","unstructured":"Miranda RN, Aladily TN, Prince HM et al (2014) Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol 32(2):114\u2013120","journal-title":"J Clin Oncol"},{"issue":"3","key":"1_CR53","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/PRS.0000000000001033","volume":"135","author":"GS Brody","year":"2015","unstructured":"Brody GS, Deapen D, Taylor CR et al (2015) Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg 135(3):695\u2013705","journal-title":"Plast Reconstr Surg"},{"issue":"17","key":"1_CR54","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/jama.2008.585","volume":"300","author":"D Jong de","year":"2008","unstructured":"de Jong D, Vasmel WL, de Boer JP et al (2008) Anaplastic large-cell lymphoma in women with breast implants. JAMA 300(17):2030\u20132035","journal-title":"JAMA"},{"issue":"5","key":"1_CR55","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/PRS.0000000000003282","volume":"139","author":"EL Doren","year":"2017","unstructured":"Doren EL, Miranda RN, Selber JC et al (2017) U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 139(5):1042\u20131050","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"1_CR56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/CEJ.0b013e328350b0ae","volume":"21","author":"J Largent","year":"2012","unstructured":"Largent J, Oefelein M, Kaplan HM, Okerson T, Boyle P (2012) Risk of lymphoma in women with breast implants: analysis of clinical studies. Eur J Cancer Prev 21(3):274\u2013280","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"1_CR57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/modpathol.3801024","volume":"21","author":"AC Roden","year":"2008","unstructured":"Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A (2008) Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 21(4):455\u2013463","journal-title":"Mod Pathol"},{"issue":"1","key":"1_CR58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAI.0b013e318266476c","volume":"21","author":"CR Taylor","year":"2013","unstructured":"Taylor CR, Siddiqi IN, Brody GS (2013) Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases. Appl Immunohistochem Mol Morphol 21(1):13\u201320","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"1_CR59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.smim.2009.03.003","volume":"21","author":"F Wijk van","year":"2009","unstructured":"van Wijk F, Cheroutre H (2009) Intestinal T cells: facing the mucosal immune dilemma with synergy and diversity. Semin Immunol 21(3):130\u2013138","journal-title":"Semin Immunol"},{"issue":"1","key":"1_CR60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","volume":"118","author":"J Delabie","year":"2011","unstructured":"Delabie J, Holte H, Vose JM et al (2011) Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 118(1):148\u2013155","journal-title":"Blood"},{"issue":"8","key":"1_CR61","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","volume":"27","author":"SY Tan","year":"2013","unstructured":"Tan SY, Chuang SS, Tang T et al (2013) Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype. Leukemia 27(8):1688\u20131696","journal-title":"Leukemia"},{"issue":"6","key":"1_CR62","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.humpath.2012.10.002","volume":"44","author":"AL Wilson","year":"2013","unstructured":"Wilson AL, Swerdlow SH, Przybylski GK et al (2013) Intestinal gammadelta T-cell lymphomas are most frequently of type II enteropathy-associated T-cell type. Hum Pathol 44(6):1131\u20131145","journal-title":"Hum Pathol"},{"issue":"10","key":"1_CR63","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","volume":"35","author":"JK Chan","year":"2011","unstructured":"Chan JK, Chan AC, Cheuk W et al (2011) Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am J Surg Pathol 35(10):1557\u20131569","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1_CR64","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.humpath.2013.10.038","volume":"45","author":"K Kikuma","year":"2014","unstructured":"Kikuma K, Yamada K, Nakamura S et al (2014) Detailed clinicopathological characteristics and possible lymphomagenesis of type II intestinal enteropathy-associated T-cell lymphoma in Japan. Hum Pathol 45(6):1276\u20131284","journal-title":"Hum Pathol"},{"issue":"5","key":"1_CR65","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","volume":"132","author":"RJ Deleeuw","year":"2007","unstructured":"Deleeuw RJ, Zettl A, Klinker E et al (2007) Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132(5):1902\u20131911","journal-title":"Gastroenterology"},{"issue":"4 Suppl 1","key":"1_CR66","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1053\/j.gastro.2005.02.027","volume":"128","author":"C Catassi","year":"2005","unstructured":"Catassi C, Bearzi I, Holmes GK (2005) Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 128(4 Suppl 1):S79\u201386","journal-title":"Gastroenterology"},{"issue":"15","key":"1_CR67","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1002\/cncr.26700","volume":"118","author":"RZ Sharaiha","year":"2012","unstructured":"Sharaiha RZ, Lebwohl B, Reimers L, Bhagat G, Green PH, Neugut AI (2012) Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008. Cancer 118(15):3786\u20133792","journal-title":"Cancer"},{"issue":"5","key":"1_CR68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","volume":"45","author":"G Malamut","year":"2013","unstructured":"Malamut G, Chandesris O, Verkarre V et al (2013) Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis 45(5):377\u2013384","journal-title":"Dig Liver Dis"},{"key":"1_CR69","doi-asserted-by":"crossref","unstructured":"van de Water JM, Cillessen SA, Visser OJ, Verbeek WH, Meijer CJ, Mulder CJ (2010) Enteropathy associated T-cell lymphoma and its precursor lesions. Best Pract Res Clin Gastroenterol 24(1):43\u201356","DOI":"10.1016\/j.bpg.2009.11.002"},{"issue":"4","key":"1_CR70","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s10620-007-9952-8","volume":"53","author":"M Silano","year":"2008","unstructured":"Silano M, Volta U, Vincenzi AD, Dessi M, Vincenzi MD (2008) Collaborating centers of the italian registry of the complications of Coeliac D. effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci 53(4):972\u2013976","journal-title":"Dig Dis Sci"},{"issue":"17","key":"1_CR71","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMra071600","volume":"357","author":"PH Green","year":"2007","unstructured":"Green PH, Cellier C (2007) Celiac disease. N Engl J Med 357(17):1731\u20131743","journal-title":"N Engl J Med"},{"key":"1_CR72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1423-0127-19-88","volume":"19","author":"F Megiorni","year":"2012","unstructured":"Megiorni F, Pizzuti A (2012) HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci 19:88","journal-title":"J Biomed Sci"},{"issue":"1","key":"1_CR73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","volume":"136","author":"G Malamut","year":"2009","unstructured":"Malamut G, Afchain P, Verkarre V et al (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136(1):81\u201390","journal-title":"Gastroenterology"},{"issue":"4","key":"1_CR74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.dld.2011.10.008","volume":"44","author":"A Amiot","year":"2012","unstructured":"Amiot A, Allez M, Treton X et al (2012) High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphoma. Dig Liver Dis. 44(4):343\u2013349","journal-title":"Dig Liver Dis."},{"issue":"4","key":"1_CR75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004836-199806000-00026","volume":"26","author":"EL Berman","year":"1998","unstructured":"Berman EL, Zauber NP, Rickert RR, Diss TC, Isaacson PG (1998) Enteropathy-associated T cell lymphoma with brain involvement. J Clin Gastroenterol 26(4):337\u2013341","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"1_CR76","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.WNL.0000066052.84194.6E","volume":"60","author":"C Gobbi","year":"2003","unstructured":"Gobbi C, Buess M, Probst A et al (2003) Enteropathy-associated T-cell lymphoma with initial manifestation in the CNS. Neurology 60(10):1718\u20131719","journal-title":"Neurology"},{"issue":"4","key":"1_CR77","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-012-0322-z","volume":"34","author":"G Malamut","year":"2012","unstructured":"Malamut G, Meresse B, Cellier C, Cerf-Bensussan N (2012) Refractory celiac disease: from bench to bedside. Semin Immunopathol. 34(4):601\u2013613","journal-title":"Semin Immunopathol."},{"issue":"5","key":"1_CR78","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/PAS.0b013e318159b478","volume":"32","author":"A Mascarel de","year":"2008","unstructured":"de Mascarel A, Belleannee G, Stanislas S et al (2008) Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am J Surg Pathol 32(5):744\u2013751","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1_CR79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gut.51.3.372","volume":"51","author":"IN Farstad","year":"2002","unstructured":"Farstad IN, Johansen FE, Vlatkovic L et al (2002) Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression. Gut 51(3):372\u2013378","journal-title":"Gut"},{"issue":"4","key":"1_CR80","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.molimm.2012.01.014","volume":"50","author":"GJ Tack","year":"2012","unstructured":"Tack GJ, van Wanrooij RL, Langerak AW et al (2012) Origin and immunophenotype of aberrant IEL in RCDII patients. Mol Immunol 50(4):262\u2013270","journal-title":"Mol Immunol"},{"issue":"4","key":"1_CR81","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gutjnl-2012-302265","volume":"62","author":"F Schmitz","year":"2013","unstructured":"Schmitz F, Tjon JM, Lai Y et al (2013) Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut 62(4):509\u2013519","journal-title":"Gut"},{"issue":"5","key":"1_CR82","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","volume":"161","author":"A Zettl","year":"2002","unstructured":"Zettl A, Ott G, Makulik A et al (2002) Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 161(5):1635\u20131645","journal-title":"Am J Pathol"},{"issue":"11","key":"1_CR83","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2016.178","volume":"30","author":"A Nicolae","year":"2016","unstructured":"Nicolae A, Xi L, Pham TH et al (2016) Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas. Leukemia 30(11):2245\u20132247","journal-title":"Leukemia"},{"key":"1_CR84","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","volume":"6","author":"C Kucuk","year":"2015","unstructured":"Kucuk C, Jiang B, Hu X et al (2015) Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells. Nat Commun 6:6025","journal-title":"Nat Commun"},{"issue":"8","key":"1_CR85","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/PAS.0b013e31822067d1","volume":"35","author":"A Garcia-Herrera","year":"2011","unstructured":"Garcia-Herrera A, Song JY, Chuang SS et al (2011) Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol 35(8):1214\u20131225","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"1_CR86","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ajh.23213","volume":"87","author":"E Tse","year":"2012","unstructured":"Tse E, Gill H, Loong F et al (2012) Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia lymphoma study group. Am J Hematol 87(7):663\u2013668","journal-title":"Am J Hematol"},{"issue":"3","key":"1_CR87","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/leu.2010.295","volume":"25","author":"SY Tan","year":"2011","unstructured":"Tan SY, Ooi AS, Ang MK et al (2011) Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma. Leukemia 25(3):555\u2013557","journal-title":"Leukemia"},{"issue":"5","key":"1_CR88","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0002-9440(10)65736-7","volume":"153","author":"A Chott","year":"1998","unstructured":"Chott A, Haedicke W, Mosberger I et al (1998) Most CD56+\u2009intestinal lymphomas are CD8+\u2009CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153(5):1483\u20131490","journal-title":"Am J Pathol"},{"issue":"10","key":"1_CR89","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/modpathol.2015.85","volume":"28","author":"S Tomita","year":"2015","unstructured":"Tomita S, Kikuti YY, Carreras J et al (2015) Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan. Mod Pathol 28(10):1286\u20131296","journal-title":"Mod Pathol"},{"issue":"7","key":"1_CR90","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/modpathol.2011.45","volume":"24","author":"J Sun","year":"2011","unstructured":"Sun J, Lu Z, Yang D, Chen J (2011) Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma. Mod Pathol 24(7):983\u2013992","journal-title":"Mod Pathol"},{"issue":"6","key":"1_CR91","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","volume":"30","author":"ML Nairismagi","year":"2016","unstructured":"Nairismagi ML, Tan J, Lim JQ et al (2016) JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia 30(6):1311\u20131319","journal-title":"Leukemia"},{"key":"1_CR92","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1038\/ncomms12602","volume":"7","author":"A Roberti","year":"2016","unstructured":"Roberti A, Dobay MP, Bisig B et al (2016) Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. Nat Commun. 7:12602","journal-title":"Nat Commun."},{"issue":"22","key":"1_CR93","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","volume":"122","author":"AM Perry","year":"2013","unstructured":"Perry AM, Warnke RA, Hu Q et al (2013) Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood 122(22):3599\u20133606","journal-title":"Blood"},{"issue":"1","key":"1_CR94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.2317","volume":"35","author":"R Matnani","year":"2017","unstructured":"Matnani R, Ganapathi KA, Lewis SK, Green PH, Alobeid B, Bhagat G (2017) Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update. Hematol Oncol 35(1):3\u201316","journal-title":"Hematol Oncol"},{"issue":"7","key":"1_CR95","doi-asserted-by":"crossref","first-page":"e68343","DOI":"10.1371\/journal.pone.0068343","volume":"8","author":"E Margolskee","year":"2013","unstructured":"Margolskee E, Jobanputra V, Lewis SK, Alobeid B, Green PH, Bhagat G (2013) Indolent small intestinal CD4+\u2009T-cell lymphoma is a distinct entity with unique biologic and clinical features. PLoS ONE 8(7):e68343","journal-title":"PLoS ONE"},{"issue":"13","key":"1_CR96","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","volume":"102","author":"K Belhadj","year":"2003","unstructured":"Belhadj K, Reyes F, Farcet JP et al (2003) Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102(13):4261\u20134269","journal-title":"Blood"},{"issue":"6","key":"1_CR97","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","volume":"20","author":"GS Falchook","year":"2009","unstructured":"Falchook GS, Vega F, Dang NH et al (2009) Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol 20(6):1080\u20131085","journal-title":"Ann Oncol"},{"issue":"6","key":"1_CR98","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","volume":"127","author":"F Vega","year":"2007","unstructured":"Vega F, Medeiros LJ, Gaulard P (2007) Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol 127(6):869\u2013880","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"1_CR99","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","volume":"25","author":"WR Macon","year":"2001","unstructured":"Macon WR, Levy NB, Kurtin PJ et al (2001) Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol 25(3):285\u2013296","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1_CR100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","volume":"7","author":"M McKinney","year":"2017","unstructured":"McKinney M, Moffitt AB, Gaulard P et al (2017) The genetic basis of hepatosplenic T-cell lymphoma. Cancer Discov 7(4):369\u2013379","journal-title":"Cancer Discov"},{"issue":"5","key":"1_CR101","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","volume":"40","author":"M Yabe","year":"2016","unstructured":"Yabe M, Medeiros LJ, Tang G et al (2016) Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases. Am J Surg Pathol 40(5):676\u2013688","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1_CR102","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/PAS.0b013e31817a9081","volume":"32","author":"YY Kong","year":"2008","unstructured":"Kong YY, Dai B, Kong JC et al (2008) Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol 32(10):1495\u20131502","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1_CR103","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","volume":"111","author":"R Willemze","year":"2008","unstructured":"Willemze R, Jansen PM, Cerroni L et al (2008) Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC cutaneous lymphoma group study of 83 cases. Blood 111(2):838\u2013845","journal-title":"Blood"},{"issue":"6","key":"1_CR104","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/PAS.0000000000000596","volume":"40","author":"RE LeBlanc","year":"2016","unstructured":"LeBlanc RE, Tavallaee M, Kim YH, Kim J (2016) Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis. Am J Surg Pathol 40(6):745\u2013754","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1_CR105","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cncr.20502","volume":"101","author":"RS Go","year":"2004","unstructured":"Go RS, Wester SM (2004) Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer 101(6):1404\u20131413","journal-title":"Cancer"},{"issue":"4","key":"1_CR106","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","volume":"28","author":"GE Janka","year":"2014","unstructured":"Janka GE, Lehmberg K (2014) Hemophagocytic syndromes\u2014an update. Blood Rev 28(4):135\u2013142","journal-title":"Blood Rev"},{"issue":"10","key":"1_CR107","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105(10):3768\u20133785","journal-title":"Blood"},{"issue":"1","key":"1_CR108","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clml.2011.06.016","volume":"12","author":"N Mehta","year":"2012","unstructured":"Mehta N, Wayne AS, Kim YH et al (2012) Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations. Clin Lymph Myeloma Leuk 12(1):20\u201325","journal-title":"Clin Lymph Myeloma Leuk"},{"key":"1_CR109","unstructured":"Jaffe ES, Organization WH (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues, IARC Press"},{"issue":"8","key":"1_CR110","first-page":"1024","volume":"136","author":"JR Toro","year":"2000","unstructured":"Toro JR, Beaty M, Sorbara L et al (2000) Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch Dermatol 136(8):1024\u20131032","journal-title":"Arch Dermatol"},{"issue":"9","key":"1_CR111","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","volume":"101","author":"JR Toro","year":"2003","unstructured":"Toro JR, Liewehr DJ, Pabby N et al (2003) Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood 101(9):3407\u20133412","journal-title":"Blood"},{"key":"1_CR112","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"S Swerdlow","year":"2008","unstructured":"Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, France"},{"issue":"4","key":"1_CR113","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2559.2000.00893.x","volume":"36","author":"C Wolf-Peeters de","year":"2000","unstructured":"de Wolf-Peeters C, Achten R (2000) gammadelta T-cell lymphomas: a homogeneous entity? Histopathology 36(4):294\u2013305","journal-title":"Histopathology"},{"issue":"5","key":"1_CR114","first-page":"1723","volume":"91","author":"B Arnulf","year":"1998","unstructured":"Arnulf B, Copie-Bergman C, Delfau-Larue MH et al (1998) Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 91(5):1723\u20131731","journal-title":"Blood"},{"issue":"4","key":"1_CR115","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","volume":"87","author":"JF Emile","year":"1996","unstructured":"Emile JF, Boulland ML, Haioun C et al (1996) CD5-CD56+\u2009T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 87(4):1466\u20131473","journal-title":"Blood"},{"issue":"12","key":"1_CR116","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","volume":"6","author":"C Tripodo","year":"2009","unstructured":"Tripodo C, Iannitto E, Florena AM et al (2009) Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol 6(12):707\u2013717","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"1_CR117","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","volume":"36","author":"J Guitart","year":"2012","unstructured":"Guitart J, Weisenburger DD, Subtil A et al (2012) Cutaneous gammadelta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas. Am J Surg Pathol 36(11):1656\u20131665","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1_CR118","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/10428190802258964","volume":"49","author":"A Amado","year":"2008","unstructured":"Amado A, McDonnell JK, Somani N, Bunting ST, Winfield HL (2008) Cutaneous gamma-delta T-cell lymphoma. Leuk Lymph 49(10):2003\u20132005","journal-title":"Leuk Lymph"},{"issue":"6","key":"1_CR119","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1309\/AJCPMG37MXKYPUBE","volume":"131","author":"M Roullet","year":"2009","unstructured":"Roullet M, Gheith SM, Mauger J, Junkins-Hopkins JM, Choi JK (2009) Percentage of {gamma}{delta} T cells in panniculitis by paraffin immunohistochemical analysis. Am J Clin Pathol 131(6):820\u2013826","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"1_CR120","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jamadermatol.2016.3117","volume":"152","author":"B Rubio-Gonzalez","year":"2016","unstructured":"Rubio-Gonzalez B, Zain J, Garcia L, Rosen ST, Querfeld C (2016) Cutaneous gamma-delta T-cell lymphoma successfully treated with brentuximab vedotin. JAMA Dermatol 152(12):1388\u20131390","journal-title":"JAMA Dermatol"},{"issue":"2","key":"1_CR121","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.clml.2015.11.013","volume":"16","author":"R Talpur","year":"2016","unstructured":"Talpur R, Chockalingam R, Wang C, Tetzlaff MT, Duvic M (2016) A single-center experience with brentuximab vedotin in gamma delta T-cell lymphoma. Clin Lymph Myeloma Leuk 16(2):e15\u201319","journal-title":"Clin Lymph Myeloma Leuk"},{"issue":"5","key":"1_CR122","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.cco.0000239879.31463.42","volume":"18","author":"R Willemze","year":"2006","unstructured":"Willemze R (2006) Primary cutaneous B-cell lymphoma: classification and treatment. Curr Opin Oncol 18(5):425\u2013431","journal-title":"Curr Opin Oncol"},{"issue":"48","key":"1_CR123","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jncimonographs\/lgu008","volume":"2014","author":"B Aschebrook-Kilfoy","year":"2014","unstructured":"Aschebrook-Kilfoy B, Cocco P, La Vecchia C et al (2014) Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sezary syndrome: the InterLymph non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014(48):98\u2013105","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"1_CR124","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archderm.138.2.182","volume":"138","author":"L Cerroni","year":"2002","unstructured":"Cerroni L, Fink-Puches R, Back B, Kerl H (2002) Follicular mucinosis: a critical reappraisal of clinicopathologic features and association with mycosis fungoides and Sezary syndrome. Arch Dermatol 138(2):182\u2013189","journal-title":"Arch Dermatol"},{"issue":"2","key":"1_CR125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.138.2.191","volume":"138","author":"R Doorn van","year":"2002","unstructured":"van Doorn R, Scheffer E, Willemze R (2002) Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch Dermatol 138(2):191\u2013198","journal-title":"Arch Dermatol"},{"issue":"8","key":"1_CR126","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2008-05-154609","volume":"112","author":"SO Arulogun","year":"2008","unstructured":"Arulogun SO, Prince HM, Ng J et al (2008) Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. Blood 112(8):3082\u20133087","journal-title":"Blood"},{"issue":"6","key":"1_CR127","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-199206000-00002","volume":"16","author":"L Cerroni","year":"1992","unstructured":"Cerroni L, Rieger E, Hodl S, Kerl H (1992) Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol 16(6):543\u2013552","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1_CR128","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N et al (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the international society for cutaneous lymphomas (ISCL) and the cutaneous lymphoma task force of the European organization of research and treatment of cancer (EORTC). Blood 110(6):1713\u20131722","journal-title":"Blood"},{"issue":"12","key":"1_CR129","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archdermatol.2012.2089","volume":"148","author":"F Cetinozman","year":"2012","unstructured":"Cetinozman F, Jansen PM, Vermeer MH, Willemze R (2012) Differential expression of programmed death-1 (PD-1) in Sezary syndrome and mycosis fungoides. Arch Dermatol 148(12):1379\u20131385","journal-title":"Arch Dermatol"},{"issue":"1","key":"1_CR130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.2004.04999.x","volume":"126","author":"K Karube","year":"2004","unstructured":"Karube K, Ohshima K, Tsuchiya T et al (2004) Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia\/lymphoma cells. Br J Haematol 126(1):81\u201384","journal-title":"Br J Haematol"},{"issue":"11","key":"1_CR131","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1517\/14712590903348135","volume":"9","author":"G Manoukian","year":"2009","unstructured":"Manoukian G, Hagemeister F (2009) Denileukin diftitox: a novel immunotoxin. Exp Opinion Biol Therapy 9(11):1445\u20131451","journal-title":"Exp Opinion Biol Therapy"},{"issue":"4","key":"1_CR132","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<539::AID-PATH465>3.0.CO;2-T","volume":"189","author":"K Ohshima","year":"1999","unstructured":"Ohshima K, Suzumiya J, Sato K et al (1999) Survival of patients with HTLV-I-associated lymph node lesions. J Pathol 189(4):539\u2013545","journal-title":"J Pathol"},{"issue":"24","key":"1_CR133","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","volume":"126","author":"H Katsuya","year":"2015","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A et al (2015) Treatment and survival among 1594 patients with ATL. Blood 126(24):2570\u20132577","journal-title":"Blood"},{"issue":"6","key":"1_CR134","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2559.1995.tb00333.x","volume":"27","author":"ES Jaffe","year":"1995","unstructured":"Jaffe ES (1995) Nasal and nasal-type T\/NK cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 27(6):581\u2013583","journal-title":"Histopathology"},{"issue":"2","key":"1_CR135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-199602000-00009","volume":"20","author":"WY Tsang","year":"1996","unstructured":"Tsang WY, Chan JK, Ng CS, Pau MY (1996) Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas. Am J Surg Pathol 20(2):202\u2013210","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"1_CR136","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0046-8177(99)90147-8","volume":"30","author":"L Quintanilla-Martinez","year":"1999","unstructured":"Quintanilla-Martinez L, Franklin JL, Guerrero I et al (1999) Histological and immunophenotypic profile of nasal NK\/T cell lymphomas from Peru: high prevalence of p53 overexpression. Hum Pathol 30(7):849\u2013855","journal-title":"Hum Pathol"},{"issue":"11","key":"1_CR137","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00000478-199411000-00013","volume":"18","author":"JK Chan","year":"1994","unstructured":"Chan JK, Tsang WY, Wong KF (1994) Classification of natural killer cell neoplasms. Am J Surg Pathol 18(11):1177\u20131179","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1_CR138","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","volume":"36","author":"T Pongpruttipan","year":"2012","unstructured":"Pongpruttipan T, Sukpanichnant S, Assanasen T et al (2012) Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta\/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol 36(4):481\u2013499","journal-title":"Am J Surg Pathol"},{"issue":"33","key":"1_CR139","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS et al (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-cell tumor study group study. J Clin Oncol 29(33):4410\u20134416","journal-title":"J Clin Oncol"}],"container-title":["Cancer Treatment and Research","T-Cell and NK-Cell Lymphomas"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-99716-2_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T05:05:26Z","timestamp":1662699926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-99716-2_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"ISBN":["9783319997155","9783319997162"],"references-count":139,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-99716-2_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-319-99716-2","asserted-by":"object"}]},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"value":"0927-3042","type":"print"},{"value":"2509-8497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}